aluates Reports

$ 0.0

Automative

Global Skin Cancer Diagnostics Therapeutics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-35H13796

Global Skin Cancer Diagnostics and Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Skin Cancer Diagnostics Therapeutics Market Research Report 2025

Code: QYRE-Auto-35H13796

Report

July 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Novartis

Qiagen NV

Abbott

Astrazeneca plc

Amgen Inc

Bristol Myers Squibb Company

F Hoffmann La Roche Ltd

Merck& Co. Inc

Sun Pharmaceutical Industries Ltd.

Skin Cancer Diagnostics Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Skin Cancer Diagnostics Therapeutics Market

The global market for Skin Cancer Diagnostics Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Skin Cancer Diagnostics Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Diagnostics Therapeutics.

The Skin Cancer Diagnostics Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Skin Cancer Diagnostics Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Skin Cancer Diagnostics Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Skin Cancer Diagnostics Therapeutics Market Report

Report Metric	Details
Report Name	Skin Cancer Diagnostics Therapeutics Market
CAGR	5%
Segment by Type	Melanoma Non-melanoma
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Amgen, AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Qiagen NV, Sun Pharmaceutical Industries Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Cancer Diagnostics Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Skin Cancer Diagnostics Therapeutics Market report?

Ans: The main players in the Skin Cancer Diagnostics Therapeutics Market are Abbott, Amgen, AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Qiagen NV, Sun Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Skin Cancer Diagnostics Therapeutics Market report?

Ans: The Applications covered in the Skin Cancer Diagnostics Therapeutics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Skin Cancer Diagnostics Therapeutics Market report?

Ans: The Types covered in the Skin Cancer Diagnostics Therapeutics Market report are Melanoma, Non-melanoma

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Melanoma/ Skin-Related

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Melanoma

1.2.3 Non-melanoma

1.3 Market by Application

1.3.1 Global Skin Cancer Diagnostics Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Skin Cancer Diagnostics Therapeutics Market Perspective (2020-2031)

2.2 Global Skin Cancer Diagnostics Therapeutics Growth Trends by Region

2.2.1 Global Skin Cancer Diagnostics Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Skin Cancer Diagnostics Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Skin Cancer Diagnostics Therapeutics Market Dynamics

2.3.1 Skin Cancer Diagnostics Therapeutics Industry Trends

2.3.2 Skin Cancer Diagnostics Therapeutics Market Drivers

2.3.3 Skin Cancer Diagnostics Therapeutics Market Challenges

2.3.4 Skin Cancer Diagnostics Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Skin Cancer Diagnostics Therapeutics Players by Revenue

3.1.1 Global Top Skin Cancer Diagnostics Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Skin Cancer Diagnostics Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Skin Cancer Diagnostics Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Skin Cancer Diagnostics Therapeutics Revenue

3.4 Global Skin Cancer Diagnostics Therapeutics Market Concentration Ratio

3.4.1 Global Skin Cancer Diagnostics Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Diagnostics Therapeutics Revenue in 2024

3.5 Global Key Players of Skin Cancer Diagnostics Therapeutics Head office and Area Served

3.6 Global Key Players of Skin Cancer Diagnostics Therapeutics, Product and Application

3.7 Global Key Players of Skin Cancer Diagnostics Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Cancer Diagnostics Therapeutics Breakdown Data by Type

4.1 Global Skin Cancer Diagnostics Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Type (2026-2031)

5 Skin Cancer Diagnostics Therapeutics Breakdown Data by Application

5.1 Global Skin Cancer Diagnostics Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Skin Cancer Diagnostics Therapeutics Market Size (2020-2031)

6.2 North America Skin Cancer Diagnostics Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025)

6.4 North America Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Skin Cancer Diagnostics Therapeutics Market Size (2020-2031)

7.2 Europe Skin Cancer Diagnostics Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025)

7.4 Europe Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Skin Cancer Diagnostics Therapeutics Market Size (2020-2031)

9.2 Latin America Skin Cancer Diagnostics Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Skin Cancer Diagnostics Therapeutics Introduction

11.1.4 Abbott Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Skin Cancer Diagnostics Therapeutics Introduction

11.2.4 Amgen Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 AstraZeneca PLC

11.3.1 AstraZeneca PLC Company Details

11.3.2 AstraZeneca PLC Business Overview

11.3.3 AstraZeneca PLC Skin Cancer Diagnostics Therapeutics Introduction

11.3.4 AstraZeneca PLC Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.3.5 AstraZeneca PLC Recent Development

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Skin Cancer Diagnostics Therapeutics Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.4.5 Bristol-Myers Squibb Company Recent Development

11.5 F. Hoffmann-La Roche Ltd

11.5.1 F. Hoffmann-La Roche Ltd Company Details

11.5.2 F. Hoffmann-La Roche Ltd Business Overview

11.5.3 F. Hoffmann-La Roche Ltd Skin Cancer Diagnostics Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Ltd Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Ltd Recent Development

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Skin Cancer Diagnostics Therapeutics Introduction

11.6.4 GlaxoSmithKline Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.6.5 GlaxoSmithKline Recent Development

11.7 Merck & Co., Inc.

11.7.1 Merck & Co., Inc. Company Details

11.7.2 Merck & Co., Inc. Business Overview

11.7.3 Merck & Co., Inc. Skin Cancer Diagnostics Therapeutics Introduction

11.7.4 Merck & Co., Inc. Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.7.5 Merck & Co., Inc. Recent Development

11.8 Novartis AG

11.8.1 Novartis AG Company Details

11.8.2 Novartis AG Business Overview

11.8.3 Novartis AG Skin Cancer Diagnostics Therapeutics Introduction

11.8.4 Novartis AG Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.8.5 Novartis AG Recent Development

11.9 Qiagen NV

11.9.1 Qiagen NV Company Details

11.9.2 Qiagen NV Business Overview

11.9.3 Qiagen NV Skin Cancer Diagnostics Therapeutics Introduction

11.9.4 Qiagen NV Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.9.5 Qiagen NV Recent Development

11.10 Sun Pharmaceutical Industries Ltd.

11.10.1 Sun Pharmaceutical Industries Ltd. Company Details

11.10.2 Sun Pharmaceutical Industries Ltd. Business Overview

11.10.3 Sun Pharmaceutical Industries Ltd. Skin Cancer Diagnostics Therapeutics Introduction

11.10.4 Sun Pharmaceutical Industries Ltd. Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

11.10.5 Sun Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Novartis

Qiagen NV

Abbott

Astrazeneca plc

Amgen Inc

Bristol Myers Squibb Company

F Hoffmann La Roche Ltd

Merck& Co. Inc

Sun Pharmaceutical Industries Ltd.

List of Tables

Table 1. Global Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Melanoma

Table 3. Key Players of Non-melanoma

Table 4. Global Skin Cancer Diagnostics Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Skin Cancer Diagnostics Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Skin Cancer Diagnostics Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Skin Cancer Diagnostics Therapeutics Market Share by Region (2020-2025)

Table 8. Global Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Skin Cancer Diagnostics Therapeutics Market Share by Region (2026-2031)

Table 10. Skin Cancer Diagnostics Therapeutics Market Trends

Table 11. Skin Cancer Diagnostics Therapeutics Market Drivers

Table 12. Skin Cancer Diagnostics Therapeutics Market Challenges

Table 13. Skin Cancer Diagnostics Therapeutics Market Restraints

Table 14. Global Skin Cancer Diagnostics Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Skin Cancer Diagnostics Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Skin Cancer Diagnostics Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics Therapeutics as of 2024)

Table 17. Ranking of Global Top Skin Cancer Diagnostics Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Skin Cancer Diagnostics Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Skin Cancer Diagnostics Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Skin Cancer Diagnostics Therapeutics, Product and Application

Table 21. Global Key Players of Skin Cancer Diagnostics Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Skin Cancer Diagnostics Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Skin Cancer Diagnostics Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Skin Cancer Diagnostics Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Skin Cancer Diagnostics Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Skin Cancer Diagnostics Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Skin Cancer Diagnostics Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Skin Cancer Diagnostics Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Skin Cancer Diagnostics Therapeutics Product

Table 49. Abbott Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Skin Cancer Diagnostics Therapeutics Product

Table 54. Amgen Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. AstraZeneca PLC Company Details

Table 57. AstraZeneca PLC Business Overview

Table 58. AstraZeneca PLC Skin Cancer Diagnostics Therapeutics Product

Table 59. AstraZeneca PLC Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca PLC Recent Development

Table 61. Bristol-Myers Squibb Company Company Details

Table 62. Bristol-Myers Squibb Company Business Overview

Table 63. Bristol-Myers Squibb Company Skin Cancer Diagnostics Therapeutics Product

Table 64. Bristol-Myers Squibb Company Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Bristol-Myers Squibb Company Recent Development

Table 66. F. Hoffmann-La Roche Ltd Company Details

Table 67. F. Hoffmann-La Roche Ltd Business Overview

Table 68. F. Hoffmann-La Roche Ltd Skin Cancer Diagnostics Therapeutics Product

Table 69. F. Hoffmann-La Roche Ltd Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 70. F. Hoffmann-La Roche Ltd Recent Development

Table 71. GlaxoSmithKline Company Details

Table 72. GlaxoSmithKline Business Overview

Table 73. GlaxoSmithKline Skin Cancer Diagnostics Therapeutics Product

Table 74. GlaxoSmithKline Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 75. GlaxoSmithKline Recent Development

Table 76. Merck & Co., Inc. Company Details

Table 77. Merck & Co., Inc. Business Overview

Table 78. Merck & Co., Inc. Skin Cancer Diagnostics Therapeutics Product

Table 79. Merck & Co., Inc. Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Merck & Co., Inc. Recent Development

Table 81. Novartis AG Company Details

Table 82. Novartis AG Business Overview

Table 83. Novartis AG Skin Cancer Diagnostics Therapeutics Product

Table 84. Novartis AG Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Novartis AG Recent Development

Table 86. Qiagen NV Company Details

Table 87. Qiagen NV Business Overview

Table 88. Qiagen NV Skin Cancer Diagnostics Therapeutics Product

Table 89. Qiagen NV Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Qiagen NV Recent Development

Table 91. Sun Pharmaceutical Industries Ltd. Company Details

Table 92. Sun Pharmaceutical Industries Ltd. Business Overview

Table 93. Sun Pharmaceutical Industries Ltd. Skin Cancer Diagnostics Therapeutics Product

Table 94. Sun Pharmaceutical Industries Ltd. Revenue in Skin Cancer Diagnostics Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Sun Pharmaceutical Industries Ltd. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Skin Cancer Diagnostics Therapeutics Picture

Figure 2. Global Skin Cancer Diagnostics Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Skin Cancer Diagnostics Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Melanoma Features

Figure 5. Non-melanoma Features

Figure 6. Global Skin Cancer Diagnostics Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Skin Cancer Diagnostics Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Skin Cancer Diagnostics Therapeutics Report Years Considered

Figure 12. Global Skin Cancer Diagnostics Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Skin Cancer Diagnostics Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Skin Cancer Diagnostics Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Skin Cancer Diagnostics Therapeutics Market Share by Players in 2024

Figure 16. Global Top Skin Cancer Diagnostics Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Skin Cancer Diagnostics Therapeutics Revenue in 2024

Figure 18. North America Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Skin Cancer Diagnostics Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Skin Cancer Diagnostics Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Skin Cancer Diagnostics Therapeutics Market Share by Region (2020-2031)

Figure 32. China Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Skin Cancer Diagnostics Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Skin Cancer Diagnostics Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Skin Cancer Diagnostics Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 49. AstraZeneca PLC Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 53. Merck & Co., Inc. Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 54. Novartis AG Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 55. Qiagen NV Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 56. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Skin Cancer Diagnostics Therapeutics Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Diagnostics Service Market Research Report 2025

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Skin Diagnosis System Market Research Report 2024

Global Non melanoma Skin Cancer Drugs Market Research Report 2024

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Tissue Diagnostics Market Research Report 2024

Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dermatology Diagnostic Tools Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions